NorthEast Community Bancorp, Inc./MD/
For the period ended Jan 28, 2026. Filed Jan 30, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jan 28, 2026 · Filed Jan 30, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Asset Quality
Asset Quality
We had no non-performing assets at December 31, 2025 compared to $5.1 million at December 31, 2024. Non-performing assets as of December 31, 2024 consisted of a foreclosed property totaling $4.3 million located in the Bronx, New York and a foreclosed property totaling $767,000 located in Pittsburgh, Pennsylvania.
The Bronx property was sold on June 30, 2025 to a third-party buyer at no loss to the Company which, in connection therewith, we provided the financing to complete the multi-family project. We charged off $222,000 in September 2025 on the Pittsburgh property and we sold the property on December 30, 2025 at a loss of $273,000.
Our ratio of non-performing assets to total assets was zero at December 31, 2025 as compared to 0.25% at December 31, 2024.
The Company’s allowance for credit losses related to loans was $4.7 million, or 0.25% of total loans as of December 31, 2025, compared to $4.8 million, or 0.27% of total loans as of December 31, 2024. Based on a review of the loans that were in the loan portfolio at December 31, 2025, management believes that the allowance for credit losses related to loans is maintained at a level that represents its best estimate of inherent losses in the loan portfolio that were both probable and reasonably estimable.
In addition, at December 31, 2025, the Company’s allowance for credit losses related to off-balance sheet commitments totaled $704,000 and the allowance for credit losses related to held-to-maturity debt securities totaled $126,000.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.